As the integration of AI technology in healthcare accelerates, Australian general practitioners (GPs) are increasingly utilizing AI scribes during patient consultations. The Royal Australian College of GPs (RACGP) anticipates that the adoption rate will rise from 22% in August 2024 to 40% by November 2025. Tools developed by startups like Heidi aim to streamline the documentation process, allowing for efficient recording and summarization of conversations.
Dr. Max Mollenkopf from Newcastle emphasizes the necessity of informing patients about the use of AI, providing them with the option to opt out. However, concerns persist regarding the clarity of patient consent, as some practitioners imply consent instead of explicitly requesting it. Dr. Elizabeth Deveny, CEO of the Consumer Health Forum, points out that this practice may lead to ethical dilemmas concerning patient autonomy.
Heidi has reported facilitating over 115 million sessions globally within a year and a half, underscoring its influence in the AI medical tool market. While many GPs believe AI scribes can reduce documentation burdens, experts caution about potential issues relating to privacy and the emotional connection between doctors and patients. Dr. Caitlin Curtis from the University of Queensland warns that automating note-taking could undermine essential cognitive processes in patient care.